{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:34:16Z","timestamp":1786649656689,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objective:<\/jats:title>\n                    <jats:p>The existence of fibromyalgia syndrome (FMS) has been debated, yet it is frequently encountered by primary care physicians and contributes to the high patient volume in neurology clinics. In India, detailed studies on fibromyalgia (FM) are lacking. This study was designed to assess the prevalence, clinical profile, and treatment outcomes of FMS in a neurology department of a government hospital in Northeast India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Hospital-based prospective observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study included adult patients aged 18 years and above attending the neurology outpatient department (OPD) who met the 2016 revision of the 2010\/2011 American College of Rheumatology (ACR) FM criteria. A total of 942 FM patients underwent systematic neurological examinations, and their neurological symptoms were assessed with a standardized questionnaire. In-depth interviews were conducted, and demographic data, clinical profiles, and treatment outcomes were recorded. Patients were followed up for 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 6,784 patients screened, 942 were diagnosed with FM, yielding a prevalence rate of 13.9%. The majority were female (90.9%). Homemakers and those in physically demanding jobs were more frequently affected. Cognitive behavioral therapy was provided to 59.9% of patients, while NSAIDs were given to 53.8% for symptomatic relief. At 6-month follow-up, 88.9% of patients reported significant improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study reveals a substantial burden of fibromyalgia among neurology outpatients in Northeast India, particularly affecting females and those in physically demanding jobs. Early diagnosis and an integrated treatment approach are crucial for improving patient outcomes and quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1174_24","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T04:30:36Z","timestamp":1742790636000},"page":"888-893","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Distress of fibromyalgia in neurology practice: A hospital based, prospective study in north eastern India - 5 years experience"],"prefix":"10.4103","volume":"14","author":[{"given":"Nalini","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, North Eastern Indira Gandhi Regional Institute of Medical Sciences, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shri R.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Neurology, North Eastern Indira Gandhi Regional Institute of Medical Sciences (Autonomous Institute, Ministry of Health and Family Welfare, Govt of India), Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiakmenlang","family":"Synmon","sequence":"additional","affiliation":[{"name":"Department of Neurology, North Eastern Indira Gandhi Regional Institute of Medical Sciences (Autonomous Institute, Ministry of Health and Family Welfare, Govt of India), Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Neurology, North Eastern Indira Gandhi Regional Institute of Medical Sciences (Autonomous Institute, Ministry of Health and Family Welfare, Govt of India), Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"R1-20250325","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","article-title":"Prevalence of fibromyalgia:Literature review update","volume":"57","author":"Marques","year":"2017","journal-title":"Rev Bras Reumatol"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia:A population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R4-20250325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr Pain Headache Rep"},{"issue":"(6 Suppl. 69)","key":"R5-20250325","first-page":"S104","article-title":"Misdiagnosis in fibromyalgia:A multicentre study","volume":"29","author":"Di Franco","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1472-6963-10-102","article-title":"A patient survey of the impact of fibromyalgia and the journey to diagnosis","volume":"10","author":"Choy","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.18410\/jebmh\/2018\/508","article-title":"Fibromyalgia:Perspective of patients, medical students and professionals","volume":"5","author":"Vasanthy","year":"2018","journal-title":"J Evid Based Med Healthc"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/PRBM.S178240","article-title":"Psychological impact of fibromyalgia:Current perspectives","volume":"12","author":"Galvez-S\u00e1nchez","year":"2019","journal-title":"Psychol Res Behav Manag"},{"key":"R10-20250325","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.mayocp.2012.02.010","article-title":"A framework for fibromyalgia management for primary care providers","volume":"87","author":"Arnold","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1759720X11416863","article-title":"Simplifying fibromyalgia assessment:The VASFIQ brief symptom scale","volume":"3","author":"Boomershine","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R12-20250325","first-page":"728","article-title":"The fibromyalgia impact questionnaire:Development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2147\/JPR.S172221","article-title":"Prevalence of fibromyalgia in fourteen Korean tertiary care university hospital pain clinics","volume":"11","author":"Lee","year":"2018","journal-title":"J Pain Res"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2310\/JIM.0b013e31824963d1","article-title":"Prevalence of fibromyalgia syndrome in patients referred to a tertiary pain clinic","volume":"60","author":"Brill","year":"2012","journal-title":"J Investig Med"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia:A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/art.24772","article-title":"Neurologic signs and symptoms in fibromyalgia","volume":"60","author":"Watson","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R17-20250325","first-page":"593","article-title":"Is fibromyalgia a neurological disease?","volume":"23","author":"Arias G\u00f3mez","year":"2008","journal-title":"Neurologia"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00325481.2018.1411743","article-title":"Normalizing fibromyalgia as a chronic illness","volume":"130","author":"Clauw","year":"2018","journal-title":"Postgrad Med"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.genm.2011.03.002","article-title":"Demographic and clinical features of patients with fibromyalgia syndrome of different settings:A gender comparison","volume":"8","author":"H\u00e4user","year":"2011","journal-title":"Gend Med"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"e0138024","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"key":"R21-20250325","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3899\/jrheum.131515","article-title":"The association of socioeconomic status and symptom severity in persons with fibromyalgia","volume":"41","author":"Fitzcharles","year":"2014","journal-title":"J Rheumatol"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1573397113666170502152955","article-title":"Work ability in fibromyalgia:An update in the 21st century","volume":"13","author":"Palstam","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"H\u00e4user","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R24-20250325","first-page":"CD013151","article-title":"Pharmacological therapies for fibromyalgia (fibromyalgia syndrome) in adults-An overview of cochrane reviews","volume":"2021","author":"Moore","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20250325","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia:Pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R26-20250325","first-page":"CD009796","article-title":"Cognitive behavioural therapies for fibromyalgia","volume":"2013","author":"Bernardy","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20250325","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncprheum0245","article-title":"Cognitive behavioral therapy for fibromyalgia","volume":"2","author":"Bennett","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R28-20250325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/AJP.0000000000000422","article-title":"Effects of cognitive-behavioral therapy (CBT) on brain connectivity supporting catastrophizing in fibromyalgia","volume":"33","author":"Lazaridou","year":"2017","journal-title":"Clin J Pain"},{"key":"R29-20250325","article-title":"Cognitive behavioural therapy for neurologists","volume":"24","author":"Stanton","year":"2023","journal-title":"Pract Neurol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1174_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:56:36Z","timestamp":1786647396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1174_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1174_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-07-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}